Archive

Feb 2018

World War 1 Memorial Works Underway

On
by admin

Work on the new World War 1 memorial for Kilkenny City is now under way and expected to be completed in June 2018.

The memorial will recognise some 825 Kilkenny men and women who lost their lives in the Great War and acknowledge more than 3,000 men and women from Kilkenny who served in the War.

The monument is being developed at the River Nore Linear Park adjacent to Michael Street. Kilgallen & Partners provided detail design services for the project. All plaques, statues, nameplates and capping stones are being cut from Kilkenny Limestone. The works are being completed by John Somers Ltd under contract with Kilkenny County Council.

Temporary Works Design for Hotel Development at North Wall Quay

On
by admin

Hotel Development at 81 & 82 North Wall Quay
Kilgallen and Partners have carried out the temporary works design for this hotel development. The design includes retention of the existing protected brick façade to enable the excavation and construction of a two storey basement and the construction of a 5 storey superstructure, temporary propping of the secant pile basement wall, temporary stability of No. 81 using internal shoring whilst ensuring the protection of the existing building fabric. The temporary works solution includes the use of shipping containers as a façade retention system, which presents a sustainable, reusable solution and has already withstood the force of Hurricane Ophelia. Kilgallen and Partners wish every success to the Client and all involved.

Developer: Oakmount Ltd.
Contractor: Glenbrier Construction Ltd.

3 Storey Facade retention – Containers and Proprietary System

Street view of containers providing facade retention

Kilgallen & Partners appointed to Takeda Ireland Ltd. Facility Upgrade

On
by admin

Kilgallen and Partners have recently been appointed as Civil Structural Consultants for Takeda Ireland’s Bray Site Facility Upgrade for Global Standards. The project is currently at design stage with construction completion in October 2018. Takeda Pharmaceutical Company Limited is a global research-based pharmaceutical company, the No 1 pharmaceutical company in Japan, and one of the world’s top 100 companies.